01 January 2008
Comparison of iron and hematological indices in Giardia lamblia infection before and after treatment in 102 children in Ahwaz, Iran
Seyed Mehdi Monajemzadeh, Maryam MonajemzadehMed Sci Monit 2008; 14(1): CR19-23 :: ID: 635945
Abstract
Background: Up to now there have been few reports about hematological alterations induced by Giardia lamblia infection. The aim of this study was to evaluate the effects of giardiasis treatment on hematological indices in children in the Khuzestan area by comparing these indices before and after treatment with metronidazole.
Material/Methods: One hundred two children ranging in age from 5 to 11 years infected with Giardia lamblia between July 2002 and July 2003 and without histories of other diseases were selected from kindergartens and primary schools in the city of Ahwaz. Diagnosis was based on stool examination. The children were treated with metronidazole (15 mg/kg/day for 5 days); hematological values were determined immediately before treatment and repeated 40-45 days after beginning treatment and compared.
Results: Iron deficiency anemia was found in 26.5% of the Giardia-infected children. Mean serum hemoglobin, serum hematocrit, serum ferritin, and the ratio of serum iron to total iron-binding capacity were increased (P<0.0001) and mean red-cell distribution width and iron-binding capacity were decreased after treatment (P<0.0001).
Conclusions: Treating giardiasis in children with metronidazole improves iron indices and it appears that in evaluating anemia one should rule out giardiasis and treat it in asymptomatic cases to aid in better health status in pediatrics.
Keywords: Erythrocyte Indices, Antiprotozoal Agents - therapeutic use, Anemia, Iron-Deficiency - etiology, Child, Preschool, Child, Ferritins - blood, Giardiasis - drug therapy, Iran, Iron - blood, Metronidazole - therapeutic use
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952